longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Guardant Health

GH

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -51.98, below the reasonable range, cheaper than 99.62% of the time in the past 1 years, and the industry ranks 59/74, the industry Median --.

-51.98xP/E
$175.65Stock price
$-3.38Earnings per share
-51.98xP/E
Stock price$175.65Earnings per share$-3.38

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-33.12x
Typical range
-44.84x–-27.44x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
07142128

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
GHUSGuardant Health
-51.98x2.92%$23.57B
HIMSUSHims & Hers Health
-45.75x209.86%$6.50B
RDNTUSRadnet
-287.42x128.00%$6.07B
WGSUSGeneDx
-26.54x359.59%$2.82B
NEOUSNeogenomics
-46.78x64.73%$2.43B
AGLUSagilon health
-6.66x93.07%$1.55B
INNVUSInnovage
-587.33x2,300.00%$1.49B
OPKUSOpko Health
-16.08x25.44%$1.17B
LMRIUSLumexa Imaging
-40.78x146.66%$1.13B
CSTLUSCastle Biosciences
-55.86x53.28%$1.08B
GMRSUSGMR Solutions
-9.09x91.45%$687.70M
FLGTUSFulgent Genetics
-6.94x42.64%$585.53M
PREUSPrenetics Global
-8.42x19.04%$395.67M
AONCUSAmerican Oncology Network
----$371.06M
BDSXUSBiodesix
-10.53x42.77%$292.27M
GAMGUSGlobal Asset Management Group, Inc.
-272.94x--$154.05M
AIRSUSAirSculpt Tech
-13.08x33.33%$153.56M
NAKAUSNakamoto
-0.33x101.83%$139.22M
CORBFUSGlobal Cord Blood Corporation
----$127.35M
PARKUSPark Dental Partners
-27.86x--$98.48M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.